AFT Pharmaceuticals | Scoop InfoPages

InfoPages

Contact

Scoop

Network

Scoop InfoPages

This InfoPage in unregistered, if this is your news page register AFT Pharmaceuticals for InfoPages here.

AFT Pharmaceuticals - Latest News [Page 1]

March Quarter FY 2026 Investor Update - FY26 Sustained Double Digit Growth Across All Markets

Tuesday, 7 April 2026, 1:13 pm | AFT Pharmaceuticals

AFT reiterates that it remains on track to deliver revenue for the year to 31 March 2027 of $300 million. More >>

Court Of Appeal Dismisses PBL Port Wine Stain Profit Claim

Monday, 9 March 2026, 10:39 am | AFT Pharmaceuticals

PBL is a company associated with a former contractor to AFT and is a 35% shareholder in AFT Orphan Pharmaceuticals Limited, a company created to pursue orphan applications. More >>

AFT And Hikma Extend US Maxigesic Cooperation

Monday, 26 May 2025, 9:01 am | AFT Pharmaceuticals

The agreement will see Hikma take over all channels for Combogesic Rapid in the US — apart from the license granted to Alexso for certain specific market categories — allowing both forms of AFT’s patented medicines to be marketed across the entire ... More >>

AFT Agrees Distribution For Crystaderm In China

Tuesday, 9 July 2024, 9:29 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today announces an agreement with Hainan Haiyao Co. Ltd (Shenzhen Stock Exchange SZ:000566) to distribute Crystaderm® cream in China, the second largest pharma market in the world*. More >>

AFT Finalises Refinancing And Gives Trading Update

Monday, 23 March 2020, 11:03 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today announces it has concluded an agreement with the Bank of New Zealand (BNZ) to refinance its current six-year CRG loan facility maturing on 31 March 2020. This follows the term sheet concluded with the BNZ which ... More >>

AFT welcomes new codeine medicine restrictions

Thursday, 5 December 2019, 9:41 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX; AFT, ASX; AFP) today welcomes Medsafe’s decision to classify all medicines containing codeine as prescription medicines. More >>

AFT and SETEK sign medicinal cannabis MoU

Tuesday, 8 October 2019, 9:08 am | AFT Pharmaceuticals

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and New Zealand medicinal cannabis company SETEK today announce they have signed a memorandum of understanding (MoU) to work together in the research, development and commercialisation of medicinal cannabis ... More >>

AFT Pharmaceuticals completes first deal in South America

Thursday, 20 June 2019, 2:00 pm | AFT Pharmaceuticals

AFT Pharmaceuticals’ completes first deal in South America AFT signs Maxigesic® Licensing Agreement with Barcelona-based Galenicum Vitae S.L.U for Colombia, Peru and Chile. More >>

AFT Pharmaceuticals establishes new borrowing facilities

Wednesday, 22 May 2019, 11:36 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) today announces it has established a NZ$15 million interim banking facility with the BNZ, enabling the company to commence refinancing its borrowings at more attractive rates. The new facility uses the existing security arrangements ... More >>

AFT Pharmaceuticals on track to return to profitability

Thursday, 22 November 2018, 9:28 am | AFT Pharmaceuticals

AFT Pharmaceuticals, manufacturer of the Maxigesic painkiller, significantly shrunk its first half loss to $0.1million from $6.7 million in the prior period, saying it remains on track to return to profitability in this financial year. More >>

Prescription-only codeine medicines in New Zealand welcomed

Thursday, 18 January 2018, 12:13 pm | AFT Pharmaceuticals

Prescription-only codeine medicines in New Zealand welcomed Yesterday the Medicines Classification Committee announced its recommendation that all codeine combination medicines, both analgesics and those used for cough and colds, should be up-scheduled ... More >>

AFT Pharmaceuticals celebrates 20 years of success

Friday, 1 September 2017, 10:08 am | AFT Pharmaceuticals

Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. More >>

Maxigesic now licensed in 124 countries worldwide

Thursday, 20 July 2017, 12:52 pm | AFT Pharmaceuticals

AFT Pharmaceutical’s painkiller Maxigesic now licensed in 124 countries worldwide AFT Pharmaceuticals (‘AFT’) has added to its existing agreements in concluding an alliance with a private European pharmaceutical company, Amicus SA Switzerland ... More >>

AFT Pharmaceuticals In-Licenses NovaTears® in Australia & NZ

Tuesday, 21 March 2017, 11:37 am | AFT Pharmaceuticals

AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Australia and New Zealand. More >>

TGA decision will boost Maxigesic sales in Australia

Tuesday, 20 December 2016, 11:33 am | AFT Pharmaceuticals

The Australian Therapeutic Goods Administration has today confirmed an interim decision that all medicines containing codeine be rescheduled to prescription-only medicines effective 1 February 2018. More >>

We all need to play our part in reducing antibiotic use

Tuesday, 22 November 2016, 11:18 am | AFT Pharmaceuticals

Managing Director of AFT Pharmaceuticals, Dr Hartley Atkinson, says that the pharmaceutical industry needs to take a leading role in helping reduce antibiotic use. More >>

New agreement for AFT Pharmaceuticals with Belgian Pharma

Friday, 23 September 2016, 11:39 am | AFT Pharmaceuticals

AFT Pharmaceuticals (‘AFT’) has executed an alliance agreement with privately-owned pharmaceutical company, Therabel Pharma NV (‘Therabel’), to license the product line of its patented combination painkiller, Maxigesic, to Belgium and Luxembourg. More >>